InvbN.18715.a
Hemagglutinin (HA)
CENTER ID:
InvbN.18715.a
ORGANISM:
Influenzavirus A Influenza A virus A/Fort Monmouth/1/1947
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
IIIC
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
InvbN.18715.a.KN11.PD38312
full length
info
18
509
PD38312
InvbN.18715.a.KN11.PD38333
full length
info
18
509
PD38333
InvbN.18715.a.TK11.PD38383
full length
info
65
276
PD38383
Structures
7JP4
DEPOSITED: 8/7/2020
DETERMINATION: XRay
CLONE: InvbN.18715.a.TK11.GE43114
PROTEIN: InvbN.18715.a.TK11.PD38383
7JPD
DEPOSITED: 8/7/2020
DETERMINATION: XRay
CLONE: InvbN.18715.a.KN11.GE42181
PROTEIN: InvbN.18715.a.KN11.PD38312
Publications by SSGCID
Structural characterisation of hemagglutinin from seven Influenza A H1N1 strains reveal diversity in the C05 antibody recognition site
Abendroth J, Baydo RO, Edwards TE, Lorimer DD, Forwood JK, Conrady DG, Stigliano M, Ghafoori SM, Calhoun BM, Peterson GF, Grice RL
Sci Rep - 2023
volume 13, issue 1, pages 6940
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MKANLLVLLC ALAAADADTI CIGYHANNST DTVDTVLEKN VTVTHSVNLL EDSHNGKLCR LKGIAPLQLG KCNIAGWILG NPECESLLSK RSWSYIAETP NSENGTCYPG DFADYEELRE QLSSVSSFER FEIFPKERSW PKHNITRGVT AACSHAGKSS FYKNLLWLTE TNGSYPKLSK SYVNNKEKEV LVLWGVHHPS NIEDQKTLYR KENAYVSVVS SNYNRRFTPE IAERPKVRGQ AGRMNYYWTL LEPGDTIIFE ANGNLIAPWY AFALSRGFGS GIITSNASMD ECDTKCQTPQ GAINSSLPFQ NIHPVTIGEC PKYVKSTKLR MVTGLRNIPS IQSRGLFGAI AGFIEGGWTG MIDGWYGYHH QNEQGSGYAA DQKSTQNAIN GITNKVNSVI EKMNTQFTAV GKEFNKLEKR MENLNKKVDD GFLDIWTYNA ELLVLLENER TLDFHDSNVK NLYEKVKNQL RNNAKEIGNG CFEFYHKCNN ECMESVKNGT YDYPKYSEES KLNREKIDGV KLESMGVYQI LAIYSTVASS LVLLVSLGAI SFWMCSNGSL QCRICI
NT Sequence
atgaaggcaa acctactggt cctgttatgt gcacttgcag ctgcagatgc agacacaata tgtataggct accatgcgaa caactcaacc gacactgttg acacagtact cgaaaagaat gtgacagtga cacactctgt aaacctactc gaagacagcc acaacgggaa attatgcaga ttaaaaggaa tagccccact acaattgggg aaatgtaaca ttgccggatg gatcttagga aacccagaat gcgaatcact gctttctaag agatcatggt cctacattgc agaaacacca aactctgaga atggaacatg ttacccagga gatttcgccg actatgagga actgagggag caattgagct cagtgtcatc attcgagaga ttcgaaatat tccccaagga aagatcatgg cccaaacaca acataaccag aggagtaacg gcagcatgct cccatgcggg gaaaagcagt ttttacaaaa atttgctctg gctgacggag acaaatggct catacccaaa gctgagcaag tcctatgtga acaataaaga gaaagaagtc cttgtgctat ggggtgttca tcacccgtct aacatagagg atcaaaagac cctctatcgg aaagaaaatg cttatgtctc tgtagtgtct tcaaattata acaggagatt caccccggaa atagcagaaa gacccaaagt aagaggtcaa gcagggagaa tgaactatta ctggactttg ctagaacccg gagacacaat aatatttgag gcaaatggaa atctaatagc gccatggtat gctttcgcac tgagtagagg ctttggatca ggaatcatca cctcaaacgc atcaatggat gaatgtgaca cgaagtgtca aacaccccag ggagctataa acagtagtct cccttttcag aatatacacc cagtcacaat aggagagtgc ccaaaatacg tcaagagtac caaattgagg atggttacag gattaaggaa catcccatcc attcaatcca gaggtctgtt tggagccatt gccggtttca ttgagggggg atggactgga atgatagatg gatggtatgg ttaccatcat cagaatgaac agggatctgg ctatgctgcg gatcaaaaaa gcacacaaaa tgcaattaac gggattacaa ataaggtgaa ctctgttatc gagaaaatga acactcaatt cacagctgtg ggtaaagaat tcaacaaatt agaaaaaaga atggaaaact taaataaaaa agttgatgat ggatttctgg acatttggac atataatgca gaattgttgg ttctactgga aaatgaaagg actttggatt tccatgactc aaatgtgaag aatctgtatg agaaagtaaa aaaccaatta aggaataatg caaaggaaat aggaaacggg tgttttgagt tctaccacaa gtgtaacaat gaatgcatgg aaagtgtaaa aaatggaact tatgattacc caaaatattc agaggaatca aagttaaaca gggaaaaaat tgatggagtg aaattggaat caatgggggt ctatcagatt ctggcgatct actcaactgt cgccagttca ctggtgcttt tggtctccct gggggcaatc agtttctgga tgtgttctaa tggatctttg cagtgcagaa tatgcatctg a
Details for InvbN.18715.a.KN11.PD38312
PURIFICATION DATe:
5/13/2018
CONCENTRATION:
9.84mg/ml
OBSERVED MW:
65kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM Tris pH 8.0, 150 mM NaCl
EXPRESSION HOST:
Sf9 cells (ES)
VIAL COUNT (approx.):
2
VIAL VOLUME:
100µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for InvbN.18715.a.KN11.PD38333
PURIFICATION DATe:
10/24/2018
CONCENTRATION:
8.66mg/ml
OBSERVED MW:
64kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
20mM Tris pH 8.0, 150mM NaCl, ~250mM Imidazole
EXPRESSION HOST:
Sf9 cells (ES)
VIAL COUNT (approx.):
1
VIAL VOLUME:
80µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for InvbN.18715.a.TK11.PD38383
PURIFICATION DATe:
8/5/2019
CONCENTRATION:
5.04mg/ml
OBSERVED MW:
26kDa
EXPRESSION LEVEL:
Low Expression
PROTEIN PURIFICATION BUFFER:
25mM tris pH 8.5, 150mM NaCl
EXPRESSION HOST:
BL21 DE3
VIAL COUNT (approx.):
9
VIAL VOLUME:
data unavailable
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable